Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 1:55 pm Purchase | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Alyeska Investment Group, L.P. | 1,830 9.990% | 1,830 (New Position) | Filing History |
| 2024-01-11 4:53 pm Purchase | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Empery Asset Management, LP | 17,399 9.990% | 17,399 (New Position) | Filing History |
| 2024-01-03 4:23 pm Purchase | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | SABBY MANAGEMENT LLC | 1,627 11.000% | 1,627 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | TANG CAPITAL PARTNERS LP | 225 7.400% | 11 (+5.14%) | Filing History |
| 2022-12-27 5:05 pm Purchase | 2022-12-16 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | TANG CAPITAL PARTNERS LP | 214 7.400% | 214 (New Position) | Filing History |
| 2022-07-08 4:52 pm Sale | 2022-06-30 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | BlackRock Inc. BLK | 17 1.100% | -31 (-64.58%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | BlackRock Inc. BLK | 48 6.200% | 48 (New Position) | Filing History |